GlaxoSmithKline plc Strikes Deal to Acquire Sierra Oncology
Sierra Oncology, Inc (Nasdaq: SRRA) surged over 37% in premarket trading after GlaxoSmithKline plc (GSK) agreed to acquire the former for $1.9 billion. Cash per Share GSK will pay $55 per share of common stock in cash representing an approximate...